JPMorgan Starts Infinity Pharmaceutical (INFI) at Overweight

January 31, 2013 6:58 AM EST Send to a Friend
Get Alerts INFI Hot Sheet
Price: $17.32 -2.31%

Rating Summary:
    11 Buy, 5 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 9 | Down: 10 | New: 35
Trade INFI Now!
Join SI Premium – FREE
JPMorgan initiates coverage on Infinity Pharmaceutical (NASDAQ: INFI) with a Overweight. PT $42.00.

For an analyst ratings summary and ratings history on Infinity Pharmaceutical click here. For more ratings news on Infinity Pharmaceutical click here.

Shares of Infinity Pharmaceutical closed at $33.37 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

New Coverage

Related Entities

JPMorgan

Add Your Comment